Shield Therapeutics's total assets for Q4 2021 were £35.82M, a decrease of -19.34% from the previous quarter. GB:STX total liabilities were £3.25M for the fiscal quarter, a -3.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.